News | May 07, 2023
Lupin to acquire French pharmaceutical company Medisol
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
New agreement applies to the polymers of the Medical Care series portfolio
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Subscribe To Our Newsletter & Stay Updated
